Author:
Legrier Marie-Emmanuelle,Bièche Ivan,Gaston Julie,Beurdeley Arnaud,Yvonnet Vanessa,Déas Olivier,Thuleau Aurélie,Château-Joubert Sophie,Servely Jean-Luc,Vacher Sophie,Lassalle Myriam,Depil Stéphane,C Tucker Gordon,Fontaine Jean-Jacques,Poupon Marie-France,Roman-Roman Sergio,Judde Jean-Gabriel,Decaudin Didier,Cairo Stefano,Marangoni Elisabetta
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Andersson BS, Mroue M, Britten RA, Murray D (1994) The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues. Cancer Res 54 (20): 5394–5400.
2. Andre F, Dieci MV, Dubsky P, Sotiriou C, Curigliano G, Denkert C, Loi S (2013) Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer. Clin Cancer Res 19 (1): 28–33.
3. Balko JM, Cook RS, Vaught DB, Kuba MG, Miller TW, Bhola NE, Sanders ME, Granja-Ingram NM, Smith JJ, Meszoely IM, Salter J, Dowsett M, Stemke-Hale K, Gonzalez-Angulo AM, Mills GB, Pinto JA, Gomez HL, Arteaga CL (2012) Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nat Med 18 (7): 1052–1059.
4. Bieche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R, Vidaud M (2001) Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 61 (4): 1652–1658.
5. Boidot R, Vegran F, Soubeyrand MS, Fumoleau P, Coudert B, Lizard-Nacol S (2009) Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinoma. Cancer Invest 27 (5): 521–528.
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献